 This study found that for Isomab, a novel antivascular endothelial growth factor, Antavegf, drug, was effective for treating wet AMD in Japanese patients. The drug showed improvement in visual acuity and retinal morphology, with no serious side effects. This article was authored by Ryo Makai, Keiko Kotoka, Koji Tanaka, and others.